TY - JOUR AU - Kumar, S. AU - Calianese, D. AU - Birge, R. B. PY - 2017 DA - 2017// TI - Efferocytosis of dying cells differentially modulate immunological outcomes in tumor microenvironment JO - Immunol Rev VL - 280 UR - https://doi.org/10.1111/imr.12587 DO - 10.1111/imr.12587 ID - Kumar2017 ER - TY - JOUR AU - Werfel, T. A. AU - Cook, R. S. PY - 2018 DA - 2018// TI - Efferocytosis in the tumor microenvironment JO - Semin Immunopathol VL - 40 UR - https://doi.org/10.1007/s00281-018-0698-5 DO - 10.1007/s00281-018-0698-5 ID - Werfel2018 ER - TY - JOUR AU - Sachet, M. AU - Liang, Y. Y. AU - Oehler, R. PY - 2017 DA - 2017// TI - The immune response to secondary necrotic cells JO - Apoptosis VL - 22 UR - https://doi.org/10.1007/s10495-017-1413-z DO - 10.1007/s10495-017-1413-z ID - Sachet2017 ER - TY - JOUR AU - Gardai, S. J. PY - 2005 DA - 2005// TI - Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte JO - Cell VL - 123 UR - https://doi.org/10.1016/j.cell.2005.08.032 DO - 10.1016/j.cell.2005.08.032 ID - Gardai2005 ER - TY - JOUR AU - Vandivier, R. W. AU - Henson, P. M. AU - Douglas, I. S. PY - 2006 DA - 2006// TI - Burying the dead: the impact of failed apoptotic cell removal (efferocytosis) on chronic inflammatory lung disease JO - Chest VL - 129 UR - https://doi.org/10.1378/chest.129.6.1673 DO - 10.1378/chest.129.6.1673 ID - Vandivier2006 ER - TY - JOUR AU - Tian, L. PY - 2016 DA - 2016// TI - Enhanced efferocytosis by dendritic cells underlies memory T-cell expansion and susceptibility to autoimmune disease in CD300f-deficient mice JO - Cell Death Differ VL - 23 UR - https://doi.org/10.1038/cdd.2015.161 DO - 10.1038/cdd.2015.161 ID - Tian2016 ER - TY - JOUR AU - Kojima, Y. AU - Weissman, I. L. AU - Leeper, N. J. PY - 2017 DA - 2017// TI - The role of Efferocytosis in atherosclerosis JO - Circulation VL - 135 UR - https://doi.org/10.1161/circulationaha.116.025684 DO - 10.1161/circulationaha.116.025684 ID - Kojima2017 ER - TY - JOUR AU - Kojima, Y. PY - 2016 DA - 2016// TI - CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis JO - Nature VL - 536 UR - https://doi.org/10.1038/nature18935 DO - 10.1038/nature18935 ID - Kojima2016 ER - TY - JOUR AU - Albert, M. L. AU - Kim, J. I. AU - Birge, R. B. PY - 2000 DA - 2000// TI - alphavbeta5 integrin recruits the CrkII-Dock180-rac1 complex for phagocytosis of apoptotic cells JO - Nat Cell Biol VL - 2 UR - https://doi.org/10.1038/35046549 DO - 10.1038/35046549 ID - Albert2000 ER - TY - JOUR AU - Monks, J. AU - Smith-Steinhart, C. AU - Kruk, E. R. AU - Fadok, V. A. AU - Henson, P. M. PY - 2008 DA - 2008// TI - Epithelial cells remove apoptotic epithelial cells during post-lactation involution of the mouse mammary gland JO - Biol Reprod VL - 78 UR - https://doi.org/10.1095/biolreprod.107.065045 DO - 10.1095/biolreprod.107.065045 ID - Monks2008 ER - TY - JOUR AU - Hermetet, F. PY - 2016 DA - 2016// TI - Efferocytosis of apoptotic human papillomavirus-positive cervical cancer cells by human primary fibroblasts JO - Biol Cell VL - 108 UR - https://doi.org/10.1111/boc.201500090 DO - 10.1111/boc.201500090 ID - Hermetet2016 ER - TY - JOUR AU - Parnaik, R. AU - Raff, M. C. AU - Scholes, J. PY - 2000 DA - 2000// TI - Differences between the clearance of apoptotic cells by professional and non-professional phagocytes JO - Curr Biol VL - 10 UR - https://doi.org/10.1016/s0960-9822(00)00598-4 DO - 10.1016/s0960-9822(00)00598-4 ID - Parnaik2000 ER - TY - JOUR AU - Bingle, L. AU - Brown, N. J. AU - Lewis, C. E. PY - 2002 DA - 2002// TI - The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies JO - J Pathol VL - 196 UR - https://doi.org/10.1002/path.1027 DO - 10.1002/path.1027 ID - Bingle2002 ER - TY - JOUR AU - Kurahara, H. PY - 2011 DA - 2011// TI - Significance of M2-polarized tumor-associated macrophage in pancreatic cancer JO - J Surg Res VL - 167 UR - https://doi.org/10.1016/j.jss.2009.05.026 DO - 10.1016/j.jss.2009.05.026 ID - Kurahara2011 ER - TY - JOUR AU - Roy, S. PY - 2018 DA - 2018// TI - Macrophage-derived Neuropilin-2 exhibits novel tumor-promoting functions JO - Cancer Res VL - 78 UR - https://doi.org/10.1158/0008-5472.can-18-0562 DO - 10.1158/0008-5472.can-18-0562 ID - Roy2018 ER - TY - JOUR AU - Lewis, C. E. AU - Pollard, J. W. PY - 2006 DA - 2006// TI - Distinct role of macrophages in different tumor microenvironments JO - Cancer Res VL - 66 UR - https://doi.org/10.1158/0008-5472.can-05-4005 DO - 10.1158/0008-5472.can-05-4005 ID - Lewis2006 ER - TY - JOUR AU - Jinushi, M. PY - 2009 DA - 2009// TI - Milk fat globule epidermal growth factor-8 blockade triggers tumor destruction through coordinated cell-autonomous and immune-mediated mechanisms JO - J Exp Med VL - 206 UR - https://doi.org/10.1084/jem.20082614 DO - 10.1084/jem.20082614 ID - Jinushi2009 ER - TY - JOUR AU - Voll, R. E. PY - 1997 DA - 1997// TI - Immunosuppressive effects of apoptotic cells JO - Nature VL - 390 UR - https://doi.org/10.1038/37022 DO - 10.1038/37022 ID - Voll1997 ER - TY - JOUR AU - Joseph, M. AU - Enting, D. PY - 2019 DA - 2019// TI - Immune responses in bladder Cancer-role of immune cell populations, prognostic factors and therapeutic implications JO - Front Oncol VL - 9 UR - https://doi.org/10.3389/fonc.2019.01270 DO - 10.3389/fonc.2019.01270 ID - Joseph2019 ER - TY - JOUR AU - Birge, R. B. PY - 2016 DA - 2016// TI - Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer JO - Cell Death Differ VL - 23 UR - https://doi.org/10.1038/cdd.2016.11 DO - 10.1038/cdd.2016.11 ID - Birge2016 ER - TY - JOUR AU - Ravichandran, K. S. PY - 2011 DA - 2011// TI - Beginnings of a good apoptotic meal: the find-me and eat-me signaling pathways JO - Immunity VL - 35 UR - https://doi.org/10.1016/j.immuni.2011.09.004 DO - 10.1016/j.immuni.2011.09.004 ID - Ravichandran2011 ER - TY - JOUR AU - Nishimura, T. PY - 2001 DA - 2001// TI - Apoptotic cells of an epithelial cell line, AsPC-1, release monocyte chemotactic S19 ribosomal protein dimer JO - J Biochem VL - 129 UR - https://doi.org/10.1093/oxfordjournals.jbchem.a002876 DO - 10.1093/oxfordjournals.jbchem.a002876 ID - Nishimura2001 ER - TY - JOUR AU - Lauber, K. PY - 2003 DA - 2003// TI - Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal JO - Cell VL - 113 UR - https://doi.org/10.1016/s0092-8674(03)00422-7 DO - 10.1016/s0092-8674(03)00422-7 ID - Lauber2003 ER - TY - JOUR AU - Lauber, K. AU - Blumenthal, S. G. AU - Waibel, M. AU - Wesselborg, S. PY - 2004 DA - 2004// TI - Clearance of apoptotic cells: getting rid of the corpses JO - Mol Cell VL - 14 UR - https://doi.org/10.1016/s1097-2765(04)00237-0 DO - 10.1016/s1097-2765(04)00237-0 ID - Lauber2004 ER - TY - JOUR AU - Gude, D. R. PY - 2008 DA - 2008// TI - Apoptosis induces expression of sphingosine kinase 1 to release sphingosine-1-phosphate as a “come-and-get-me” signal JO - FASEB J VL - 22 UR - https://doi.org/10.1096/fj.08-107169 DO - 10.1096/fj.08-107169 ID - Gude2008 ER - TY - JOUR AU - Truman, L. A. PY - 2008 DA - 2008// TI - CX3CL1/fractalkine is released from apoptotic lymphocytes to stimulate macrophage chemotaxis JO - Blood VL - 112 UR - https://doi.org/10.1182/blood-2008-06-162404 DO - 10.1182/blood-2008-06-162404 ID - Truman2008 ER - TY - JOUR AU - Elliott, M. R. PY - 2009 DA - 2009// TI - Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance JO - Nature VL - 461 UR - https://doi.org/10.1038/nature08296 DO - 10.1038/nature08296 ID - Elliott2009 ER - TY - JOUR AU - Martin, S. J. PY - 1995 DA - 1995// TI - Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl JO - J Exp Med VL - 182 UR - https://doi.org/10.1084/jem.182.5.1545 DO - 10.1084/jem.182.5.1545 ID - Martin1995 ER - TY - JOUR AU - Fadok, V. A. PY - 1992 DA - 1992// TI - Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages JO - J Immunol (Baltimore, Md : 1950) VL - 148 ID - Fadok1992 ER - TY - JOUR AU - Miyanishi, M. PY - 2007 DA - 2007// TI - Identification of Tim4 as a phosphatidylserine receptor JO - Nature VL - 450 UR - https://doi.org/10.1038/nature06307 DO - 10.1038/nature06307 ID - Miyanishi2007 ER - TY - JOUR AU - Kobayashi, N. PY - 2007 DA - 2007// TI - TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells JO - Immunity VL - 27 UR - https://doi.org/10.1016/j.immuni.2007.11.011 DO - 10.1016/j.immuni.2007.11.011 ID - Kobayashi2007 ER - TY - JOUR AU - Park, D. PY - 2007 DA - 2007// TI - BAI1 is an engulfment receptor for apoptotic cells upstream of the ELMO/Dock180/Rac module JO - Nature VL - 450 UR - https://doi.org/10.1038/nature06329 DO - 10.1038/nature06329 ID - Park2007 ER - TY - JOUR AU - Park, S. Y. PY - 2008 DA - 2008// TI - Rapid cell corpse clearance by stabilin-2, a membrane phosphatidylserine receptor JO - Cell Death Differ VL - 15 UR - https://doi.org/10.1038/sj.cdd.4402242 DO - 10.1038/sj.cdd.4402242 ID - Park2008 ER - TY - JOUR AU - Murakami, Y. PY - 2014 DA - 2014// TI - CD300b regulates the phagocytosis of apoptotic cells via phosphatidylserine recognition JO - Cell Death Differ VL - 21 UR - https://doi.org/10.1038/cdd.2014.86 DO - 10.1038/cdd.2014.86 ID - Murakami2014 ER - TY - JOUR AU - Tian, L. PY - 2014 DA - 2014// TI - p85alpha recruitment by the CD300f phosphatidylserine receptor mediates apoptotic cell clearance required for autoimmunity suppression JO - Nat Commun VL - 5 UR - https://doi.org/10.1038/ncomms4146 DO - 10.1038/ncomms4146 ID - Tian2014 ER - TY - JOUR AU - He, M. PY - 2011 DA - 2011// TI - Receptor for advanced glycation end products binds to phosphatidylserine and assists in the clearance of apoptotic cells JO - EMBO Rep VL - 12 UR - https://doi.org/10.1038/embor.2011.28 DO - 10.1038/embor.2011.28 ID - He2011 ER - TY - JOUR AU - Meer, J. H. AU - Poll, T. AU - Veer, C. PY - 2014 DA - 2014// TI - TAM receptors, Gas6, and protein S: roles in inflammation and hemostasis JO - Blood VL - 123 UR - https://doi.org/10.1182/blood-2013-09-528752 DO - 10.1182/blood-2013-09-528752 ID - Meer2014 ER - TY - JOUR AU - Zhu, C. AU - Wei, Y. AU - Wei, X. PY - 2019 DA - 2019// TI - AXL receptor tyrosine kinase as a promising anti-cancer approach: functions, molecular mechanisms and clinical applications JO - Mol Cancer VL - 18 UR - https://doi.org/10.1186/s12943-019-1090-3 DO - 10.1186/s12943-019-1090-3 ID - Zhu2019 ER - TY - JOUR AU - Hanayama, R. PY - 2004 DA - 2004// TI - Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice JO - Science (New York, NY) VL - 304 UR - https://doi.org/10.1126/science.1094359 DO - 10.1126/science.1094359 ID - Hanayama2004 ER - TY - JOUR AU - Ramirez-Ortiz, Z. G. PY - 2013 DA - 2013// TI - The scavenger receptor SCARF1 mediates the clearance of apoptotic cells and prevents autoimmunity JO - Nat Immunol VL - 14 UR - https://doi.org/10.1038/ni.2670 DO - 10.1038/ni.2670 ID - Ramirez-Ortiz2013 ER - TY - JOUR AU - Brown, S. PY - 2002 DA - 2002// TI - Apoptosis disables CD31-mediated cell detachment from phagocytes promoting binding and engulfment JO - Nature VL - 418 UR - https://doi.org/10.1038/nature00811 DO - 10.1038/nature00811 ID - Brown2002 ER - TY - JOUR AU - Fadok, V. A. PY - 1998 DA - 1998// TI - Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF JO - J Clin Invest VL - 101 UR - https://doi.org/10.1172/jci1112 DO - 10.1172/jci1112 ID - Fadok1998 ER - TY - JOUR AU - Huynh, M. L. AU - Fadok, V. A. AU - Henson, P. M. PY - 2002 DA - 2002// TI - Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation JO - J Clin Invest VL - 109 UR - https://doi.org/10.1172/jci11638 DO - 10.1172/jci11638 ID - Huynh2002 ER - TY - JOUR AU - Tibrewal, N. PY - 2008 DA - 2008// TI - Autophosphorylation docking site Tyr-867 in Mer receptor tyrosine kinase allows for dissociation of multiple signaling pathways for phagocytosis of apoptotic cells and down-modulation of lipopolysaccharide-inducible NF-kappaB transcriptional activation JO - J Biol Chem VL - 283 UR - https://doi.org/10.1074/jbc.M706906200 DO - 10.1074/jbc.M706906200 ID - Tibrewal2008 ER - TY - JOUR AU - Camenisch, T. D. AU - Koller, B. H. AU - Earp, H. S. AU - Matsushima, G. K. PY - 1999 DA - 1999// TI - A novel receptor tyrosine kinase, Mer, inhibits TNF-alpha production and lipopolysaccharide-induced endotoxic shock JO - J Immunol (Baltimore, Md : 1950) VL - 162 ID - Camenisch1999 ER - TY - JOUR AU - Loeser, S. PY - 2007 DA - 2007// TI - Spontaneous tumor rejection by cbl-b-deficient CD8+ T cells JO - J Exp Med VL - 204 UR - https://doi.org/10.1084/jem.20061699 DO - 10.1084/jem.20061699 ID - Loeser2007 ER - TY - JOUR AU - Paolino, M. PY - 2014 DA - 2014// TI - The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells JO - Nature VL - 507 UR - https://doi.org/10.1038/nature12998 DO - 10.1038/nature12998 ID - Paolino2014 ER - TY - JOUR AU - Cook, R. S. PY - 2013 DA - 2013// TI - MerTK inhibition in tumor leukocytes decreases tumor growth and metastasis JO - J Clin Invest VL - 123 UR - https://doi.org/10.1172/jci67655 DO - 10.1172/jci67655 ID - Cook2013 ER - TY - JOUR AU - Chao, M. P. PY - 2010 DA - 2010// TI - Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma JO - Cell VL - 142 UR - https://doi.org/10.1016/j.cell.2010.07.044 DO - 10.1016/j.cell.2010.07.044 ID - Chao2010 ER - TY - JOUR AU - Knocke, S. PY - 2016 DA - 2016// TI - Tailored tumor immunogenicity reveals regulation of CD4 and CD8 T cell responses against Cancer JO - Cell Rep VL - 17 UR - https://doi.org/10.1016/j.celrep.2016.10.086 DO - 10.1016/j.celrep.2016.10.086 ID - Knocke2016 ER - TY - JOUR AU - Desrichard, A. AU - Snyder, A. AU - Chan, T. A. PY - 2016 DA - 2016// TI - Cancer Neoantigens and applications for immunotherapy JO - Clin Cancer Res VL - 22 UR - https://doi.org/10.1158/1078-0432.Ccr-14-3175 DO - 10.1158/1078-0432.Ccr-14-3175 ID - Desrichard2016 ER - TY - JOUR AU - Werfel, T. A. PY - 2019 DA - 2019// TI - Treatment-induced tumor cell apoptosis and secondary necrosis drive tumor progression in the residual tumor microenvironment through MerTK and IDO1 JO - Cancer Res VL - 79 UR - https://doi.org/10.1158/0008-5472.can-18-1106 DO - 10.1158/0008-5472.can-18-1106 ID - Werfel2019 ER - TY - JOUR AU - Pollard, J. W. PY - 2004 DA - 2004// TI - Tumour-educated macrophages promote tumour progression and metastasis JO - Nat Rev Cancer VL - 4 UR - https://doi.org/10.1038/nrc1256 DO - 10.1038/nrc1256 ID - Pollard2004 ER - TY - JOUR AU - Akalu, Y. T. AU - Rothlin, C. V. AU - Ghosh, S. PY - 2017 DA - 2017// TI - TAM receptor tyrosine kinases as emerging targets of innate immune checkpoint blockade for cancer therapy JO - Immunol Rev VL - 276 UR - https://doi.org/10.1111/imr.12522 DO - 10.1111/imr.12522 ID - Akalu2017 ER - TY - JOUR AU - Linger, R. M. AU - Keating, A. K. AU - Earp, H. S. AU - Graham, D. K. PY - 2008 DA - 2008// TI - TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer JO - Adv Cancer Res VL - 100 UR - https://doi.org/10.1016/s0065-230x(08)00002-x DO - 10.1016/s0065-230x(08)00002-x ID - Linger2008 ER - TY - JOUR AU - Rochlitz, C. PY - 1999 DA - 1999// TI - Axl expression is associated with adverse prognosis and with expression of Bcl-2 and CD34 in de novo acute myeloid leukemia (AML): results from a multicenter trial of the Swiss Group for Clinical Cancer Research (SAKK) JO - Leukemia VL - 13 UR - https://doi.org/10.1038/sj.leu.2401484 DO - 10.1038/sj.leu.2401484 ID - Rochlitz1999 ER - TY - JOUR AU - Nguyen, K. Q. PY - 2014 DA - 2014// TI - Overexpression of MERTK receptor tyrosine kinase in epithelial cancer cells drives efferocytosis in a gain-of-function capacity JO - J Biol Chem VL - 289 UR - https://doi.org/10.1074/jbc.M114.570838 DO - 10.1074/jbc.M114.570838 ID - Nguyen2014 ER - TY - JOUR AU - Vergadi, E. AU - Ieronymaki, E. AU - Lyroni, K. AU - Vaporidi, K. AU - Tsatsanis, C. PY - 2017 DA - 2017// TI - Akt signaling pathway in macrophage activation and M1/M2 polarization JO - J Immunol (Baltimore, Md : 1950) VL - 198 UR - https://doi.org/10.4049/jimmunol.1601515 DO - 10.4049/jimmunol.1601515 ID - Vergadi2017 ER - TY - JOUR AU - Myers, K. V. AU - Amend, S. R. AU - Pienta, K. J. PY - 2019 DA - 2019// TI - Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment JO - Mol Cancer VL - 18 UR - https://doi.org/10.1186/s12943-019-1022-2 DO - 10.1186/s12943-019-1022-2 ID - Myers2019 ER - TY - JOUR AU - Nishi, C. AU - Toda, S. AU - Segawa, K. AU - Nagata, S. PY - 2014 DA - 2014// TI - Tim4- and MerTK-mediated engulfment of apoptotic cells by mouse resident peritoneal macrophages JO - Mol Cell Biol VL - 34 UR - https://doi.org/10.1128/mcb.01394-13 DO - 10.1128/mcb.01394-13 ID - Nishi2014 ER - TY - JOUR AU - Yan, D. PY - 2018 DA - 2018// TI - MERTK promotes resistance to irreversible EGFR tyrosine kinase inhibitors in non-small cell lung cancers expressing wild-type EGFR family members JO - Clin Cancer Res VL - 24 UR - https://doi.org/10.1158/1078-0432.ccr-18-0040 DO - 10.1158/1078-0432.ccr-18-0040 ID - Yan2018 ER - TY - STD TI - Lew ED, et al. Differential TAM receptor-ligand-phospholipid interactions delimit differential TAM bioactivities. eLife. 2014;3. https://doi.org/10.7554/eLife.03385. ID - ref62 ER - TY - JOUR AU - Vouri, M. PY - 2016 DA - 2016// TI - Axl-EGFR receptor tyrosine kinase hetero-interaction provides EGFR with access to pro-invasive signalling in cancer cells JO - Oncogenesis VL - 5 UR - https://doi.org/10.1038/oncsis.2016.66 DO - 10.1038/oncsis.2016.66 ID - Vouri2016 ER - TY - JOUR AU - Korshunov, V. A. AU - Mohan, A. M. AU - Georger, M. A. AU - Berk, B. C. PY - 2006 DA - 2006// TI - Axl, a receptor tyrosine kinase, mediates flow-induced vascular remodeling JO - Circ Res VL - 98 UR - https://doi.org/10.1161/01.RES.0000223322.16149.9a DO - 10.1161/01.RES.0000223322.16149.9a ID - Korshunov2006 ER - TY - JOUR AU - Goyette, M. A. PY - 2018 DA - 2018// TI - The receptor tyrosine kinase AXL is required at multiple steps of the metastatic Cascade during HER2-positive breast Cancer progression JO - Cell Rep VL - 23 UR - https://doi.org/10.1016/j.celrep.2018.04.019 DO - 10.1016/j.celrep.2018.04.019 ID - Goyette2018 ER - TY - JOUR AU - Dent, P. PY - 2014 DA - 2014// TI - Crosstalk between ERK, AKT, and cell survival JO - Cancer Biol Ther VL - 15 UR - https://doi.org/10.4161/cbt.27541 DO - 10.4161/cbt.27541 ID - Dent2014 ER - TY - JOUR AU - Lin, J. Z. PY - 2017 DA - 2017// TI - Targeting AXL overcomes resistance to docetaxel therapy in advanced prostate cancer JO - Oncotarget VL - 8 UR - https://doi.org/10.18632/oncotarget.17026 DO - 10.18632/oncotarget.17026 ID - Lin2017 ER - TY - JOUR AU - Giles, K. M. PY - 2013 DA - 2013// TI - Axl mediates acquired resistance of head and neck cancer cells to the epidermal growth factor receptor inhibitor erlotinib JO - Mol Cancer Ther VL - 12 UR - https://doi.org/10.1158/1535-7163.mct-13-0170 DO - 10.1158/1535-7163.mct-13-0170 ID - Giles2013 ER - TY - JOUR AU - Tian, Y. PY - 2016 DA - 2016// TI - Anexelekto (AXL) increases resistance to EGFR-TKI and activation of AKT and ERK1/2 in non-small cell lung Cancer cells JO - Oncol Res VL - 24 UR - https://doi.org/10.3727/096504016x14648701447814 DO - 10.3727/096504016x14648701447814 ID - Tian2016 ER - TY - JOUR AU - Sen, T. PY - 2017 DA - 2017// TI - Targeting AXL and mTOR pathway overcomes primary and acquired resistance to WEE1 inhibition in small-cell lung Cancer JO - Clin Cancer Res VL - 23 UR - https://doi.org/10.1158/1078-0432.ccr-17-1284 DO - 10.1158/1078-0432.ccr-17-1284 ID - Sen2017 ER - TY - JOUR AU - Chiang, J. Y. AU - Jang, I. K. AU - Hodes, R. AU - Gu, H. PY - 2007 DA - 2007// TI - Ablation of Cbl-b provides protection against transplanted and spontaneous tumors JO - J Clin Invest VL - 117 UR - https://doi.org/10.1172/jci29472 DO - 10.1172/jci29472 ID - Chiang2007 ER - TY - JOUR AU - Wohlfert, E. A. AU - Callahan, M. K. AU - Clark, R. B. PY - 2004 DA - 2004// TI - Resistance to CD4+CD25+ regulatory T cells and TGF-beta in Cbl-b−/− mice JO - J Immunol (Baltimore, Md : 1950) VL - 173 UR - https://doi.org/10.4049/jimmunol.173.2.1059 DO - 10.4049/jimmunol.173.2.1059 ID - Wohlfert2004 ER - TY - JOUR AU - Gheibi Hayat, S. M. AU - Bianconi, V. AU - Pirro, M. AU - Sahebkar, A. PY - 2019 DA - 2019// TI - Efferocytosis: molecular mechanisms and pathophysiological perspectives JO - Immunol Cell Biol VL - 97 UR - https://doi.org/10.1111/imcb.12206 DO - 10.1111/imcb.12206 ID - Gheibi Hayat2019 ER - TY - JOUR AU - Flannagan, R. S. AU - Canton, J. AU - Furuya, W. AU - Glogauer, M. AU - Grinstein, S. PY - 2014 DA - 2014// TI - The phosphatidylserine receptor TIM4 utilizes integrins as coreceptors to effect phagocytosis JO - Mol Biol Cell VL - 25 UR - https://doi.org/10.1091/mbc.E13-04-0212 DO - 10.1091/mbc.E13-04-0212 ID - Flannagan2014 ER - TY - JOUR AU - Zhang, Q. PY - 2015 DA - 2015// TI - TIM-4 promotes the growth of non-small-cell lung cancer in a RGD motif-dependent manner JO - Br J Cancer VL - 113 UR - https://doi.org/10.1038/bjc.2015.323 DO - 10.1038/bjc.2015.323 ID - Zhang2015 ER - TY - JOUR AU - Baghdadi, M. PY - 2013 DA - 2013// TI - TIM-4 glycoprotein-mediated degradation of dying tumor cells by autophagy leads to reduced antigen presentation and increased immune tolerance JO - Immunity VL - 39 UR - https://doi.org/10.1016/j.immuni.2013.09.014 DO - 10.1016/j.immuni.2013.09.014 ID - Baghdadi2013 ER - TY - JOUR AU - Tan, X. AU - Zhang, Z. AU - Yao, H. AU - Shen, L. PY - 2018 DA - 2018// TI - Tim-4 promotes the growth of colorectal cancer by activating angiogenesis and recruiting tumor-associated macrophages via the PI3K/AKT/mTOR signaling pathway JO - Cancer Lett VL - 436 UR - https://doi.org/10.1016/j.canlet.2018.08.012 DO - 10.1016/j.canlet.2018.08.012 ID - Tan2018 ER - TY - JOUR AU - Sainaghi, P. P. PY - 2005 DA - 2005// TI - Gas6 induces proliferation in prostate carcinoma cell lines expressing the Axl receptor JO - J Cell Physiol VL - 204 UR - https://doi.org/10.1002/jcp.20265 DO - 10.1002/jcp.20265 ID - Sainaghi2005 ER - TY - JOUR AU - Loges, S. PY - 2010 DA - 2010// TI - Malignant cells fuel tumor growth by educating infiltrating leukocytes to produce the mitogen Gas6 JO - Blood VL - 115 UR - https://doi.org/10.1182/blood-2009-06-228684 DO - 10.1182/blood-2009-06-228684 ID - Loges2010 ER - TY - JOUR AU - Oba, J. PY - 2011 DA - 2011// TI - Expression of milk fat globule epidermal growth factor-VIII may be an indicator of poor prognosis in malignant melanoma JO - Br J Dermatol VL - 165 UR - https://doi.org/10.1111/j.1365-2133.2011.10409.x DO - 10.1111/j.1365-2133.2011.10409.x ID - Oba2011 ER - TY - JOUR AU - Fens, M. H. PY - 2008 DA - 2008// TI - Angiogenic endothelium shows lactadherin-dependent phagocytosis of aged erythrocytes and apoptotic cells JO - Blood VL - 111 UR - https://doi.org/10.1182/blood-2007-06-094763 DO - 10.1182/blood-2007-06-094763 ID - Fens2008 ER - TY - JOUR AU - Li, B. Z. AU - Zhang, H. Y. AU - Pan, H. F. AU - Ye, D. Q. PY - 2013 DA - 2013// TI - Identification of MFG-E8 as a novel therapeutic target for diseases JO - Expert Opin Ther Targets VL - 17 UR - https://doi.org/10.1517/14728222.2013.829455 DO - 10.1517/14728222.2013.829455 ID - Li2013 ER - TY - JOUR AU - Jia, M. PY - 2017 DA - 2017// TI - Prognostic correlation between MFG-E8 expression level and colorectal Cancer JO - Arch Med Res VL - 48 UR - https://doi.org/10.1016/j.arcmed.2017.06.003 DO - 10.1016/j.arcmed.2017.06.003 ID - Jia2017 ER - TY - JOUR AU - Yu, L. PY - 2019 DA - 2019// TI - MFG-E8 overexpression is associated with poor prognosis in breast cancer patients JO - Pathol Res Pract VL - 215 UR - https://doi.org/10.1016/j.prp.2018.12.036 DO - 10.1016/j.prp.2018.12.036 ID - Yu2019 ER - TY - JOUR AU - Kanemura, T. PY - 2018 DA - 2018// TI - Immunoregulatory influence of abundant MFG-E8 expression by esophageal cancer treated with chemotherapy JO - Cancer Sci VL - 109 UR - https://doi.org/10.1111/cas.13785 DO - 10.1111/cas.13785 ID - Kanemura2018 ER - TY - JOUR AU - Yamada, K. PY - 2016 DA - 2016// TI - MFG-E8 drives melanoma growth by stimulating mesenchymal stromal cell-induced angiogenesis and M2 polarization of tumor-associated macrophages JO - Cancer Res VL - 76 UR - https://doi.org/10.1158/0008-5472.can-15-2812 DO - 10.1158/0008-5472.can-15-2812 ID - Yamada2016 ER - TY - JOUR AU - Soki, F. N. PY - 2014 DA - 2014// TI - Polarization of prostate cancer-associated macrophages is induced by milk fat globule-EGF factor 8 (MFG-E8)-mediated efferocytosis JO - J Biol Chem VL - 289 UR - https://doi.org/10.1074/jbc.M114.571620 DO - 10.1074/jbc.M114.571620 ID - Soki2014 ER - TY - JOUR AU - Chalasani, P. PY - 2015 DA - 2015// TI - A phase I clinical trial of bavituximab and paclitaxel in patients with HER2 negative metastatic breast cancer JO - Cancer Med VL - 4 UR - https://doi.org/10.1002/cam4.447 DO - 10.1002/cam4.447 ID - Chalasani2015 ER - TY - JOUR AU - Digumarti, R. PY - 2014 DA - 2014// TI - Bavituximab plus paclitaxel and carboplatin for the treatment of advanced non-small-cell lung cancer JO - Lung Cancer (Amsterdam, Netherlands) VL - 86 UR - https://doi.org/10.1016/j.lungcan.2014.08.010 DO - 10.1016/j.lungcan.2014.08.010 ID - Digumarti2014 ER - TY - JOUR AU - Gerber, D. E. PY - 2011 DA - 2011// TI - Phase I safety and pharmacokinetic study of bavituximab, a chimeric phosphatidylserine-targeting monoclonal antibody, in patients with advanced solid tumors JO - Clin Cancer Res VL - 17 UR - https://doi.org/10.1158/1078-0432.ccr-11-1074 DO - 10.1158/1078-0432.ccr-11-1074 ID - Gerber2011 ER - TY - JOUR AU - McDaniel, N. K. PY - 2018 DA - 2018// TI - MERTK mediates intrinsic and adaptive resistance to AXL-targeting agents JO - Mol Cancer Ther VL - 17 UR - https://doi.org/10.1158/1535-7163.mct-17-1239 DO - 10.1158/1535-7163.mct-17-1239 ID - McDaniel2018 ER - TY - JOUR AU - Duan, Y. PY - 2019 DA - 2019// TI - A novel human anti-AXL monoclonal antibody attenuates tumour cell migration JO - Scand J Immunol VL - 90 UR - https://doi.org/10.1111/sji.12777 DO - 10.1111/sji.12777 ID - Duan2019 ER - TY - JOUR AU - Costa, M. AU - Bellosta, P. AU - Basilico, C. PY - 1996 DA - 1996// TI - Cleavage and release of a soluble form of the receptor tyrosine kinase ARK in vitro and in vivo JO - J Cell Physiol VL - 168 UR - https://doi.org/3.0.co;2-u DO - 3.0.co;2-u ID - Costa1996 ER - TY - JOUR AU - Lee, Y. J. AU - Kim, S. Y. AU - Lee, C. PY - 2019 DA - 2019// TI - Axl is a novel target of celastrol that inhibits cell proliferation and migration, and increases the cytotoxicity of gefitinib in EGFR mutant nonsmall cell lung cancer cells JO - Mol Med Rep VL - 19 UR - https://doi.org/10.3892/mmr.2019.9957 DO - 10.3892/mmr.2019.9957 ID - Lee2019 ER - TY - JOUR AU - Paccez, J. D. PY - 2019 DA - 2019// TI - Dihydroartemisinin inhibits prostate cancer via JARID2/miR-7/miR-34a-dependent downregulation of Axl JO - Oncogenesis VL - 8 UR - https://doi.org/10.1038/s41389-019-0122-6 DO - 10.1038/s41389-019-0122-6 ID - Paccez2019 ER - TY - JOUR AU - Zhao, J. Y. PY - 2015 DA - 2015// TI - Down-regulation of MFG-E8 by RNA interference combined with doxorubicin triggers melanoma destruction JO - Clin Exp Med VL - 15 UR - https://doi.org/10.1007/s10238-014-0277-6 DO - 10.1007/s10238-014-0277-6 ID - Zhao2015 ER - TY - JOUR AU - Banerjee, S. PY - 2011 DA - 2011// TI - Intracellular HMGB1 negatively regulates efferocytosis JO - J Immunol (Baltimore, Md : 1950) VL - 187 UR - https://doi.org/10.4049/jimmunol.1101500 DO - 10.4049/jimmunol.1101500 ID - Banerjee2011 ER - TY - JOUR AU - Friggeri, A. PY - 2010 DA - 2010// TI - HMGB1 inhibits macrophage activity in efferocytosis through binding to the alphavbeta3-integrin JO - Am J Phys Cell Phys VL - 299 UR - https://doi.org/10.1152/ajpcell.00152.2010 DO - 10.1152/ajpcell.00152.2010 ID - Friggeri2010 ER - TY - JOUR AU - Kim, D. PY - 2012 DA - 2012// TI - Anti-CD47 antibodies promote phagocytosis and inhibit the growth of human myeloma cells JO - Leukemia VL - 26 UR - https://doi.org/10.1038/leu.2012.141 DO - 10.1038/leu.2012.141 ID - Kim2012 ER - TY - JOUR AU - Chao, M. P. PY - 2011 DA - 2011// TI - Extranodal dissemination of non-Hodgkin lymphoma requires CD47 and is inhibited by anti-CD47 antibody therapy JO - Blood VL - 118 UR - https://doi.org/10.1182/blood-2011-02-338020 DO - 10.1182/blood-2011-02-338020 ID - Chao2011 ER - TY - JOUR AU - Yang, M. AU - Liu, J. AU - Piao, C. AU - Shao, J. AU - Du, J. PY - 2015 DA - 2015// TI - ICAM-1 suppresses tumor metastasis by inhibiting macrophage M2 polarization through blockade of efferocytosis JO - Cell Death Dis VL - 6 UR - https://doi.org/10.1038/cddis.2015.144 DO - 10.1038/cddis.2015.144 ID - Yang2015 ER - TY - JOUR AU - Gerke, V. AU - Creutz, C. E. AU - Moss, S. E. PY - 2005 DA - 2005// TI - Annexins: linking Ca2+ signalling to membrane dynamics JO - Nat Rev Mol Cell Biol VL - 6 UR - https://doi.org/10.1038/nrm1661 DO - 10.1038/nrm1661 ID - Gerke2005 ER - TY - JOUR AU - Munoz, L. E. PY - 2007 DA - 2007// TI - The influence on the immunomodulatory effects of dying and dead cells of Annexin V JO - J Leukoc Biol VL - 81 UR - https://doi.org/10.1189/jlb.0306166 DO - 10.1189/jlb.0306166 ID - Munoz2007 ER - TY - JOUR AU - Stach, C. M. PY - 2000 DA - 2000// TI - Treatment with annexin V increases immunogenicity of apoptotic human T-cells in Balb/c mice JO - Cell Death Differ VL - 7 UR - https://doi.org/10.1038/sj.cdd.4400715 DO - 10.1038/sj.cdd.4400715 ID - Stach2000 ER - TY - JOUR AU - DeRose, P. AU - Thorpe, P. E. AU - Gerber, D. E. PY - 2011 DA - 2011// TI - Development of bavituximab, a vascular targeting agent with immune-modulating properties, for lung cancer treatment JO - Immunotherapy VL - 3 UR - https://doi.org/10.2217/imt.11.87 DO - 10.2217/imt.11.87 ID - DeRose2011 ER - TY - JOUR AU - Ran, S. AU - Downes, A. AU - Thorpe, P. E. PY - 2002 DA - 2002// TI - Increased exposure of anionic phospholipids on the surface of tumor blood vessels JO - Cancer Res VL - 62 ID - Ran2002 ER - TY - JOUR AU - Huang, X. AU - Bennett, M. AU - Thorpe, P. E. PY - 2005 DA - 2005// TI - A monoclonal antibody that binds anionic phospholipids on tumor blood vessels enhances the antitumor effect of docetaxel on human breast tumors in mice JO - Cancer Res VL - 65 UR - https://doi.org/10.1158/0008-5472.can-05-0031 DO - 10.1158/0008-5472.can-05-0031 ID - Huang2005 ER - TY - JOUR AU - Yin, Y. AU - Huang, X. AU - Lynn, K. D. AU - Thorpe, P. E. PY - 2013 DA - 2013// TI - Phosphatidylserine-targeting antibody induces M1 macrophage polarization and promotes myeloid-derived suppressor cell differentiation JO - Cancer Immunol Res VL - 1 UR - https://doi.org/10.1158/2326-6066.cir-13-0073 DO - 10.1158/2326-6066.cir-13-0073 ID - Yin2013 ER - TY - JOUR AU - Gerber, D. E. PY - 2016 DA - 2016// TI - Docetaxel combined with Bavituximab in previously treated, advanced nonsquamous non-small-cell lung Cancer JO - Clin Lung Cancer VL - 17 UR - https://doi.org/10.1016/j.cllc.2016.02.003 DO - 10.1016/j.cllc.2016.02.003 ID - Gerber2016 ER - TY - JOUR AU - Onken, J. PY - 2016 DA - 2016// TI - Inhibiting receptor tyrosine kinase AXL with small molecule inhibitor BMS-777607 reduces glioblastoma growth, migration, and invasion in vitro and in vivo JO - Oncotarget VL - 7 UR - https://doi.org/10.18632/oncotarget.7130 DO - 10.18632/oncotarget.7130 ID - Onken2016 ER - TY - JOUR AU - Balaji, K. PY - 2017 DA - 2017// TI - AXL inhibition suppresses the DNA damage response and sensitizes cells to PARP inhibition in multiple cancers JO - Mol Cancer Res VL - 15 UR - https://doi.org/10.1158/1541-7786.mcr-16-0157 DO - 10.1158/1541-7786.mcr-16-0157 ID - Balaji2017 ER - TY - JOUR AU - Liu, L. PY - 2009 DA - 2009// TI - Novel mechanism of lapatinib resistance in HER2-positive breast tumor cells: activation of AXL JO - Cancer Res VL - 69 UR - https://doi.org/10.1158/0008-5472.can-08-4490 DO - 10.1158/0008-5472.can-08-4490 ID - Liu2009 ER - TY - JOUR AU - Weinger, J. G. PY - 2011 DA - 2011// TI - Loss of the receptor tyrosine kinase Axl leads to enhanced inflammation in the CNS and delayed removal of myelin debris during experimental autoimmune encephalomyelitis JO - J Neuroinflammation VL - 8 UR - https://doi.org/10.1186/1742-2094-8-49 DO - 10.1186/1742-2094-8-49 ID - Weinger2011 ER - TY - JOUR AU - Miller, M. A. PY - 2016 DA - 2016// TI - Reduced proteolytic shedding of receptor tyrosine kinases is a post-translational mechanism of kinase inhibitor resistance JO - Cancer Discov VL - 6 UR - https://doi.org/10.1158/2159-8290.cd-15-0933 DO - 10.1158/2159-8290.cd-15-0933 ID - Miller2016 ER - TY - JOUR AU - Kariolis, M. S. PY - 2014 DA - 2014// TI - An engineered Axl ‘decoy receptor’ effectively silences the Gas6-Axl signaling axis JO - Nat Chem Biol VL - 10 UR - https://doi.org/10.1038/nchembio.1636 DO - 10.1038/nchembio.1636 ID - Kariolis2014 ER - TY - JOUR AU - Sawyers, C. L. PY - 2003 DA - 2003// TI - Opportunities and challenges in the development of kinase inhibitor therapy for cancer JO - Genes Dev VL - 17 UR - https://doi.org/10.1101/gad.1152403 DO - 10.1101/gad.1152403 ID - Sawyers2003 ER - TY - JOUR AU - Leconet, W. PY - 2014 DA - 2014// TI - Preclinical validation of AXL receptor as a target for antibody-based pancreatic cancer immunotherapy JO - Oncogene VL - 33 UR - https://doi.org/10.1038/onc.2013.487 DO - 10.1038/onc.2013.487 ID - Leconet2014 ER - TY - JOUR AU - Chames, P. AU - Regenmortel, M. AU - Weiss, E. AU - Baty, D. PY - 2009 DA - 2009// TI - Therapeutic antibodies: successes, limitations and hopes for the future JO - Br J Pharmacol VL - 157 UR - https://doi.org/10.1111/j.1476-5381.2009.00190.x DO - 10.1111/j.1476-5381.2009.00190.x ID - Chames2009 ER - TY - JOUR AU - Lu, Q. AU - Lemke, G. PY - 2001 DA - 2001// TI - Homeostatic regulation of the immune system by receptor tyrosine kinases of the tyro 3 family JO - Science (New York, NY) VL - 293 UR - https://doi.org/10.1126/science.1061663 DO - 10.1126/science.1061663 ID - Lu2001 ER - TY - JOUR AU - Ksantini, M. AU - Lafont, E. AU - Bocquet, B. AU - Meunier, I. AU - Hamel, C. P. PY - 2012 DA - 2012// TI - Homozygous mutation in MERTK causes severe autosomal recessive retinitis pigmentosa JO - Eur J Ophthalmol VL - 22 UR - https://doi.org/10.5301/ejo.5000096 DO - 10.5301/ejo.5000096 ID - Ksantini2012 ER - TY - JOUR AU - Chen, F. L. AU - Xia, W. AU - Spector, N. L. PY - 2008 DA - 2008// TI - Acquired resistance to small molecule ErbB2 tyrosine kinase inhibitors JO - Clin Cancer Res VL - 14 UR - https://doi.org/10.1158/1078-0432.ccr-08-0581 DO - 10.1158/1078-0432.ccr-08-0581 ID - Chen2008 ER - TY - JOUR AU - Mancini, M. PY - 2015 DA - 2015// TI - Combining three antibodies nullifies feedback-mediated resistance to erlotinib in lung cancer JO - Sci Signal VL - 8 UR - https://doi.org/10.1126/scisignal.aaa0725 DO - 10.1126/scisignal.aaa0725 ID - Mancini2015 ER - TY - JOUR AU - Yamaguchi, H. AU - Chang, S. S. AU - Hsu, J. L. AU - Hung, M. C. PY - 2014 DA - 2014// TI - Signaling cross-talk in the resistance to HER family receptor targeted therapy JO - Oncogene VL - 33 UR - https://doi.org/10.1038/onc.2013.74 DO - 10.1038/onc.2013.74 ID - Yamaguchi2014 ER - TY - JOUR AU - Kawada, I. PY - 2014 DA - 2014// TI - Dramatic antitumor effects of the dual MET/RON small-molecule inhibitor LY2801653 in non-small cell lung cancer JO - Cancer Res VL - 74 UR - https://doi.org/10.1158/0008-5472.can-12-3583 DO - 10.1158/0008-5472.can-12-3583 ID - Kawada2014 ER - TY - JOUR AU - Kasikara, C. PY - 2017 DA - 2017// TI - Phosphatidylserine sensing by TAM receptors regulates AKT-dependent Chemoresistance and PD-L1 expression JO - Mol Cancer Res VL - 15 UR - https://doi.org/10.1158/1541-7786.mcr-16-0350 DO - 10.1158/1541-7786.mcr-16-0350 ID - Kasikara2017 ER - TY - JOUR AU - Jinushi, M. PY - 2008 DA - 2008// TI - Milk fat globule EGF-8 promotes melanoma progression through coordinated Akt and twist signaling in the tumor microenvironment JO - Cancer Res VL - 68 UR - https://doi.org/10.1158/0008-5472.can-08-2147 DO - 10.1158/0008-5472.can-08-2147 ID - Jinushi2008 ER - TY - JOUR AU - Jinushi, M. PY - 2007 DA - 2007// TI - MFG-E8-mediated uptake of apoptotic cells by APCs links the pro- and antiinflammatory activities of GM-CSF JO - J Clin Invest VL - 117 UR - https://doi.org/10.1172/jci30966 DO - 10.1172/jci30966 ID - Jinushi2007 ER - TY - JOUR AU - Neutzner, M. PY - 2007 DA - 2007// TI - MFG-E8/lactadherin promotes tumor growth in an angiogenesis-dependent transgenic mouse model of multistage carcinogenesis JO - Cancer Res VL - 67 UR - https://doi.org/10.1158/0008-5472.can-07-0165 DO - 10.1158/0008-5472.can-07-0165 ID - Neutzner2007 ER - TY - JOUR AU - Sugano, G. PY - 2011 DA - 2011// TI - Milk fat globule--epidermal growth factor--factor VIII (MFGE8)/lactadherin promotes bladder tumor development JO - Oncogene VL - 30 UR - https://doi.org/10.1038/onc.2010.446 DO - 10.1038/onc.2010.446 ID - Sugano2011 ER - TY - JOUR AU - Hanayama, R. PY - 2002 DA - 2002// TI - Identification of a factor that links apoptotic cells to phagocytes JO - Nature VL - 417 UR - https://doi.org/10.1038/417182a DO - 10.1038/417182a ID - Hanayama2002 ER - TY - JOUR AU - Akitake-Kawano, R. PY - 2013 DA - 2013// TI - Inhibitory role of Gas6 in intestinal tumorigenesis JO - Carcinogenesis VL - 34 UR - https://doi.org/10.1093/carcin/bgt069 DO - 10.1093/carcin/bgt069 ID - Akitake-Kawano2013 ER - TY - JOUR AU - Bosurgi, L. PY - 2013 DA - 2013// TI - Paradoxical role of the proto-oncogene Axl and Mer receptor tyrosine kinases in colon cancer JO - Proc Natl Acad Sci U S A VL - 110 UR - https://doi.org/10.1073/pnas.1302507110 DO - 10.1073/pnas.1302507110 ID - Bosurgi2013 ER - TY - JOUR AU - Ravichandran, K. S. PY - 2010 DA - 2010// TI - Find-me and eat-me signals in apoptotic cell clearance: progress and conundrums JO - J Exp Med VL - 207 UR - https://doi.org/10.1084/jem.20101157 DO - 10.1084/jem.20101157 ID - Ravichandran2010 ER - TY - JOUR AU - Willingham, S. B. PY - 2012 DA - 2012// TI - The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors JO - Proc Natl Acad Sci U S A VL - 109 UR - https://doi.org/10.1073/pnas.1121623109 DO - 10.1073/pnas.1121623109 ID - Willingham2012 ER - TY - JOUR AU - Jaiswal, S. AU - Chao, M. P. AU - Majeti, R. AU - Weissman, I. L. PY - 2010 DA - 2010// TI - Macrophages as mediators of tumor immunosurveillance JO - Trends Immunol VL - 31 UR - https://doi.org/10.1016/j.it.2010.04.001 DO - 10.1016/j.it.2010.04.001 ID - Jaiswal2010 ER - TY - JOUR AU - Wyckoff, J. B. PY - 2007 DA - 2007// TI - Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors JO - Cancer Res VL - 67 UR - https://doi.org/10.1158/0008-5472.can-06-1823 DO - 10.1158/0008-5472.can-06-1823 ID - Wyckoff2007 ER - TY - JOUR AU - Brown, E. J. AU - Frazier, W. A. PY - 2001 DA - 2001// TI - Integrin-associated protein (CD47) and its ligands JO - Trends Cell Biol VL - 11 UR - https://doi.org/10.1016/s0962-8924(00)01906-1 DO - 10.1016/s0962-8924(00)01906-1 ID - Brown2001 ER - TY - JOUR AU - Majeti, R. PY - 2009 DA - 2009// TI - CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells JO - Cell VL - 138 UR - https://doi.org/10.1016/j.cell.2009.05.045 DO - 10.1016/j.cell.2009.05.045 ID - Majeti2009 ER - TY - JOUR AU - Obeid, M. PY - 2007 DA - 2007// TI - Calreticulin exposure is required for the immunogenicity of gamma-irradiation and UVC light-induced apoptosis JO - Cell Death Differ VL - 14 UR - https://doi.org/10.1038/sj.cdd.4402201 DO - 10.1038/sj.cdd.4402201 ID - Obeid2007 ER - TY - JOUR AU - Obeid, M. PY - 2007 DA - 2007// TI - Calreticulin exposure dictates the immunogenicity of cancer cell death JO - Nat Med VL - 13 UR - https://doi.org/10.1038/nm1523 DO - 10.1038/nm1523 ID - Obeid2007 ER - TY - JOUR AU - Clynes, R. A. AU - Towers, T. L. AU - Presta, L. G. AU - Ravetch, J. V. PY - 2000 DA - 2000// TI - Inhibitory fc receptors modulate in vivo cytotoxicity against tumor targets JO - Nat Med VL - 6 UR - https://doi.org/10.1038/74704 DO - 10.1038/74704 ID - Clynes2000 ER - TY - JOUR AU - Staunton, D. E. AU - Marlin, S. D. AU - Stratowa, C. AU - Dustin, M. L. AU - Springer, T. A. PY - 1988 DA - 1988// TI - Primary structure of ICAM-1 demonstrates interaction between members of the immunoglobulin and integrin supergene families JO - Cell VL - 52 UR - https://doi.org/10.1016/0092-8674(88)90434-5 DO - 10.1016/0092-8674(88)90434-5 ID - Staunton1988 ER - TY - JOUR AU - Hubbard, A. K. AU - Rothlein, R. PY - 2000 DA - 2000// TI - Intercellular adhesion molecule-1 (ICAM-1) expression and cell signaling cascades JO - Free Radic Biol Med VL - 28 UR - https://doi.org/10.1016/s0891-5849(00)00223-9 DO - 10.1016/s0891-5849(00)00223-9 ID - Hubbard2000 ER - TY - JOUR AU - Hamai, A. PY - 2008 DA - 2008// TI - ICAM-1 has a critical role in the regulation of metastatic melanoma tumor susceptibility to CTL lysis by interfering with PI3K/AKT pathway JO - Cancer Res VL - 68 UR - https://doi.org/10.1158/0008-5472.can-08-0719 DO - 10.1158/0008-5472.can-08-0719 ID - Hamai2008 ER -